Beleave Signs Letter of Intent with Seven Oaks Cannabis
Jan 03, 2018 12:25 pm UTC| Business
TORONTO, Jan. 03, 2018 -- Beleave Inc. ("Beleave" or the "Company") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has signed a letter of intent with Seven Oaks Cannabis Inc. (“Seven Oaks”) for Seven Oaks to...
Spoon In Lid Packaging Market is set to reach US$ 1,558.8 Mn in 2026 - TMR
Jan 03, 2018 12:18 pm UTC| Business
Albany, New York, Jan. 03, 2018 -- Strong competition in packaging market is driving the companies to invest in innovation, in order to ensure success. Companies across the globe are redesigning their product packaging...
Jan 03, 2018 12:05 pm UTC| Business
Senior pharmaceutical executives with extensive experience in immuno-oncology, drug development, commercializing oncology medications and finance TEL AVIV, Israel, Jan. 03, 2018 -- VBL Therapeutics (NASDAQ:VBLT),...
Immunovaccine to Present at 2018 Biotech Showcase™ Conference
Jan 03, 2018 12:05 pm UTC| Business
HALIFAX, Nova Scotia, Jan. 03, 2018 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will participate in the 10th Annual Biotech Showcase...
Myriad Genetics Announces Expanded Research Collaboration with AstraZeneca
Jan 03, 2018 12:05 pm UTC| Business
SALT LAKE CITY, Jan. 03, 2018 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that AstraZeneca will use the Company’s myChoice® HRD Plus in an...
Shire plc : Xiidra® Approved by Health Canada To Treat the Signs and Symptoms of Dry Eye Disease
Jan 03, 2018 12:01 pm UTC| Business
Xiidra®* (Lifitegrast Ophthalmic Solution 5%) Approved by Health Canada To Treat the Signs and Symptoms of Dry Eye Disease Canada approval represents Shire's first international market authorization for Xiidra...
Emergent BioSolutions to Participate in First Quarter 2018 Investor Conferences
Jan 03, 2018 12:01 pm UTC| Business
GAITHERSBURG, Md., Jan. 03, 2018 -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the first...